MILPRO 4 MG/10 MG FILM-COATED TABLETS FOR SMALL CATS AND KITTENS

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

MILBEMYCIN OXIME, PRAZIQUANTEL

Available from:

Virbac S.A.

ATC code:

QP54AB51

INN (International Name):

MILBEMYCIN OXIME, PRAZIQUANTEL

Dosage:

4/10 mg/tablet

Pharmaceutical form:

Tablets

Prescription type:

POM

Therapeutic group:

Feline

Therapeutic area:

Milbemycin, combinations

Therapeutic indications:

Endoparasiticide

Authorization status:

Authorised

Authorization date:

2014-08-15

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Milpro 4 mg/10 mg film-coated tablets for small cats and kittens
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Film coated tablet.
Oval shaped, dark brown, meat flavoured tablets with a score on both
sides.
The tablets can be divided into halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats (small cats and kittens).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cats: treatment of mixed infections by immature and adult cestodes
(tapeworms) and adult nematodes (roundworms)
of the following species:
Cestodes:
_Echinococcus multilocularis,_
_Dipylidium caninum,_
_Taenia_ spp_.,_
Nematodes:
_Ancylostoma tubaeforme,_
_Toxocara cati_
The product can also be used in the prevention of heartworm disease
(_Dirofilaria immitis_),
if concomitant
treatment
against cestodes is indicated.
4.3 CONTRAINDICATIONS
Do not use in kittens of less than 6 weeks of age and/or weighing less
than 0.5 kg.
Do not use in cases of hypersensitivity to the active substances or to
any of the excipients.
Each tablet contains:
ACTIVE SUBSTANCES:
Milbemycin Oxime
4
mg
Praziquantel
10 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_7_
_/_
_0_
_2_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_8_
_9_
_5_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
It is recommended to treat all the